Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
Ten patients with superficial infantile hemangiomas were treated with imiquimod 5% cream for up to 16 weeks. Four patients achieved complete clinical resolution, 3 had excellent improvement, one showed moderate improvement, and one patient did not respond to therapy. Imiquimod may be an effective alternative for the treatment of superficial hemangiomas.
Welsh
Oliverio
O
Department of Dermatology at the University Hospital UANL Madero y Gonzalitos, Col. Mitras Centro Monterrey, Monterrey, NL, México.owelsh@yahoo.com
Olazarán
Zulema
Z
Gómez
Minerva
M
Salas
Julio
J
Berman
Brian
B
D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D000077271:Imiquimod; D007223:Infant; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod